| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 57894-080-60 | 57894-080 | HUMAN PRESCRIPTION DRUG | LAZCLUZE | lazertinib | TABLET, FILM COATED | ORAL | 20240820 | N/A | NDA | NDA219008 | Janssen Biotech, Inc. | LAZERTINIB | 80 mg/1 | 1 BOTTLE in 1 CARTON (57894-080-60) / 60 TABLET, FILM COATED in 1 BOTTLE |
| 57894-080-90 | 57894-080 | HUMAN PRESCRIPTION DRUG | LAZCLUZE | lazertinib | TABLET, FILM COATED | ORAL | 20240820 | N/A | NDA | NDA219008 | Janssen Biotech, Inc. | LAZERTINIB | 80 mg/1 | 1 BOTTLE in 1 CARTON (57894-080-90) / 90 TABLET, FILM COATED in 1 BOTTLE |
| 57894-240-30 | 57894-240 | HUMAN PRESCRIPTION DRUG | LAZCLUZE | lazertinib | TABLET, FILM COATED | ORAL | 20240820 | N/A | NDA | NDA219008 | Janssen Biotech, Inc. | LAZERTINIB | 240 mg/1 | 1 BOTTLE in 1 CARTON (57894-240-30) / 30 TABLET, FILM COATED in 1 BOTTLE |
| 57894-240-99 | 57894-240 | HUMAN PRESCRIPTION DRUG | LAZCLUZE | lazertinib | TABLET, FILM COATED | ORAL | 20240820 | N/A | NDA | NDA219008 | Janssen Biotech, Inc. | LAZERTINIB | 240 mg/1 | 1 DOSE PACK in 1 CARTON (57894-240-99) / 14 TABLET, FILM COATED in 1 DOSE PACK |